Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

British Journal of Cancer

Volumn 83, Issue 3, 2000, Pages 324-328

  Tomozawa, S ^a   Tsuno, N H ^b   Sunami, E ^a   Hatano, K ^a   Kitayama, J ^a   Osada, T ^b   Saito, S ^a   Tsuruo, T ^b   Shibata, Y ^b   Nagawa, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colorectal cancer; COX 2; Haematogenous metastasis; Immunohistochemistry; Recurrence

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; STROMA CELL;

EID: 0033923699     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1270     Document Type: Article

References (35)

1. Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T and Takahashi T (1999) Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5: 1001-1005
2. DuBois RN, Awad J, Morrow J, Roberts LJ 2nd and Bishop PR (1994) Regulation of eicosannid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 93: 493-498
3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN (1994) Up-regulation of cyclooxygcnase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188
4. Folkman J (1990) What is the evidence that tumours are angiogenesis dependent? [editorial]. J Natl Cancer Inst 82: 4-6
5. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM and Sugihara K (1998) Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 58: 4823-4826
6. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A and Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals [see comments]. Ann Intern Med 121: 241-246
7. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC and Speizer FE (1995) Aspirin and the risk of colorectal cancer in women [see comments]. N Engl J Med 333: 609-614
8. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T and Takahashi T (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58: 3761-3764
9. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris AL (1992) Angiogcnesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
10. Hwang D, Scollard D, Byrne J and Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460
11. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA and Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049-9054
12. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559
13. Kawamori T, Rao CV, Seibert K and Reddy BS (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412
14. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR (1991) TIS10, a phorbol ester tumour promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 12866-12872
15. Liotta LA, Rao CN and Wewer UM (1986) Biochemical interactions of tumour cells with the basement membrane. Annu Rev Biochem 55: 1037-1057
16. Mahadevan V and Hart IR (1990) Metastasis and angiogenesis. Acta Oncol 29: 97-103
17. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
18. Marnett LJ (1995) Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med 24: 103-106
19. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H and Hori M (1999) Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94: 451-455
20. O'Banion MK, Sadowski HB, Winn V and Young DA (1991) A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266: 23261-23267
21. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM (1996) Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809
22. Reddy BS, Rao CV and Seibert K (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56: 4566-4569
23. Ristimaki A, Honkanen N, Jankala H, Sipponen P and Harkonen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280
24. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789
25. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp, RD and DuBois RN (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259
26. Thun MJ, Namboodiri MM and Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer [see comments]. N Engl J Med 325: 1593-1596
27. Thun MJ, Namboodiri MM, Calle EE, Flanders WD and Heath CW Jr (1993) Aspirin use and risk of fatal cancer [see Comments]. Cancer Rev 53: 1322-1327
28. Tomozawa S, Nagawa H, Tsuno N, Hatano K., Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H, Tsuruo T, Shibata Y and Muto T (1999) Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81: 1274-1279
29. Tsujii M and DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501
30. Tsujii M, Kawano S and DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340
31. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells [published erratum appears in Cell 1998; 94(2): following 271]. Cell 93: 705-716
32. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT and Fahey TJ 3rd (1999) Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Rex 59: 987-990
33. Williams CS and DuBois RN (1996) Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270: G393-G400
34. Xie W and Herschman HR (1995) v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270: 27622-27628
35. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE and Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198-204